Thematic area:
Algorithms and AI/ML Models
Product:
A clinically proven, app-based adolescent obesity treatment platform integrating behavioural interventions, clinician dashboards, sensor based monitoring, and personalised treatment plans. RDOPV2 enhances the original system with real-time analytics, communication tools, and broader platform support (iOS & Android).
Market:
Adolescent obesity affects 10% of European youth, with rapidly rising demand for remote treatment. RDOP targets families, hospitals, insurers, paediatric obesity clinics, and national health systems. The associated global obesity treatment market may reach $100B by 2030.
Fit:
Existing digital obesity tools are not clinically validated or tailored to adolescents. RDOP fills a gap for safe, non-stigmatizing, long-term care that complements pharmacotherapy. Strong evidence base, validated clinical demand, and clear spinout potential provide a strong product–market fit.
